+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dipyridamole"

Acute Ischemic Stroke Therapeutics Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Dipyridamole is a drug used in the treatment of cardiovascular diseases. It is an antiplatelet agent, meaning it helps to prevent the formation of blood clots. It is used to reduce the risk of stroke in patients with atrial fibrillation, and to prevent blood clots in patients who have had a heart attack or who have had a stent placed in their coronary artery. It is also used to reduce the risk of recurrent stroke in patients who have had a transient ischemic attack (TIA). Dipyridamole is available in both oral and intravenous forms. The dipyridamole market is a part of the larger cardiovascular drugs market. It is a growing market, driven by the increasing prevalence of cardiovascular diseases and the need for effective treatments. The market is expected to continue to grow in the coming years, as new treatments are developed and the demand for existing treatments increases. Some of the companies in the dipyridamole market include Pfizer, Sanofi, Merck, Novartis, and Bayer. Show Less Read more